Northern Trust’s Vigil Neuroscience VIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-71,588
Closed -$569K 4545
2025
Q2
$569K Buy
71,588
+10,469
+17% +$46.9K ﹤0.01% 3609
2025
Q1
$109K Sell
61,119
-3,618
-6% -$8.12K ﹤0.01% 4093
2024
Q4
$110K Buy
64,737
+14,572
+29% +$43K ﹤0.01% 4136
2024
Q3
$171K Sell
50,165
-83,438
-62% -$309K ﹤0.01% 3925
2024
Q2
$534K Sell
133,603
-5,117
-4% -$17.5K ﹤0.01% 3486
2024
Q1
$473K Sell
138,720
-2,681
-2% -$8.37K ﹤0.01% 3581
2023
Q4
$478K Buy
141,401
+15,667
+12% +$80.6K ﹤0.01% 3549
2023
Q3
$678K Buy
125,734
+1,372
+1% +$9.48K ﹤0.01% 3428
2023
Q2
$1.17M Buy
124,362
+102,127
+459% +$966K ﹤0.01% 3297
2023
Q1
$218K Buy
22,235
+3,441
+18% +$38.7K ﹤0.01% 3821
2022
Q4
$235K Buy
18,794
+6,712
+56% +$82.4K ﹤0.01% 3794
2022
Q3
$110K Hold
12,082
﹤0.01% 4084
2022
Q2
$31K Sell
12,082
-44,601
-79% -$176K ﹤0.01% 4547
2022
Q1
$398K Buy
+56,683
New +$748K ﹤0.01% 3833

Other funds holding VIGL